Bachem is a leading, innovation-driven com­pany specializing in the development and manufacture of peptides and oligonucleotides. With 50 years of experience and expertise, Bachem provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services. Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange. For further infor­mation, see www.bachem.com.